Methylphenidate modulates cerebral post-stroke reorganization

Jean Tardy1, Jérémie Pariente, Anne Leger

  • 1INSERM U455, Pavillon Riser, Purpan Hospital, Toulouse, France. tardyjean@yahoo.fr

Neuroimage
|September 19, 2006
PubMed
Abstract

Insights

Methylphenidate (MP) improved motor function in stroke patients by enhancing brain activation in motor areas. This suggests MP may aid recovery by modulating attention and effort networks post-stroke.

Area of Science:

  • Neuroscience
  • Neurology
  • Rehabilitation Medicine

Background:

  • Subcortical stroke can impair motor function due to damage to the corticospinal tract.
  • Understanding how to modulate brain activity and behavior after stroke is crucial for developing effective rehabilitation strategies.

Purpose of the Study:

  • To investigate the effects of a single dose of methylphenidate (MP) on cerebral motor activation and behavioral outcomes in patients with subcortical stroke.
  • To test the hypothesis that MP can modulate motor network function and improve motor performance in affected limbs.

Main Methods:

  • A randomized, cross-over, double-blind, placebo-controlled study involving eight male patients with pure motor hemiparesis post-stroke.
  • Functional magnetic resonance imaging (fMRI) and validated motor tests (including finger tapping) were used to assess brain activity and motor performance.
  • Patients were evaluated twice, receiving either 20 mg MP or placebo in a counterbalanced order, with each patient serving as their own control.

Main Results:

  • Methylphenidate (MP) significantly improved motor performance in the affected hand compared to placebo, as measured by the finger tapping test.
  • MP induced hyperactivation in the ipsilesional primary sensorimotor cortex (including hand and face areas) and contralesional premotor cortex.
  • MP also led to hypoactivation in the ipsilesional anterior cingulum, with face area hyperactivation correlating positively with performance improvement.

Conclusions:

  • The findings demonstrate that methylphenidate can effectively target the reorganized neural network in stroke patients.
  • The therapeutic effect of MP may be partly attributed to enhanced attention and effort, potentially mediated by modulation of the cingulum.
  • MP shows potential as an adjunct therapy to improve motor function and facilitate neurorehabilitation after subcortical stroke.

Related Concept Videos